+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

APAC CRISPR Gene Editing Market 2021-2031

  • PDF Icon

    Report

  • 126 Pages
  • February 2022
  • Region: Asia Pacific
  • GMD Research
  • ID: 5552826
Asia Pacific CRISPR Gene Editing market will grow by 28.6% annually with a total addressable market cap of $21.45 billion over 2022-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic.



Highlighted with 35 tables and 53 figures, this 126-page report “Asia Pacific CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific CRISPR Gene Editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific CRISPR Gene Editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Country.

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • CRISPR Products
  • Kits & Enzymes
  • Vector-Based Cas9
  • DNA-Free Cas9
  • Databases & Libraries
  • Design Tools
  • Antibodies
  • CRISPR Plasmid & Vector
  • Other Products
  • CRISPR Services
  • gRNA Design & Vector Construction
  • Cell Line Engineering
  • Microbial Gene Editing
  • DNA Synthesis
  • Other Services

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Biomedical Research & Therapy
  • Gene Therapy
  • Drug Discovery
  • Diagnostics
  • Other Biomedical Applications
  • Agriculture
  • Industrial Use
  • Other Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutions & Research Centers
  • Other End Users

Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Offering, Application, and End User, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • Abcam, Inc.
  • Agilent Technologies, Inc.
  • Applied StemCell, Inc.
  • Caribou Biosciences, Inc.
  • Cellecta, Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GeneCopoeia, Inc.
  • GeneScript Biotech Corporation
  • Horizon Discovery Group PLC
  • Integrated DNA Technologies, Inc.
  • Intellia Therapeutics Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Rockland Immunochemicals, Inc.
  • Synthego Corporation
  • System Biosciences LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • ToolGen, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the APAC CRISPR Gene Editing Market

What is the estimated value of the APAC CRISPR Gene Editing Market?

The APAC CRISPR Gene Editing Market was estimated to be valued at $381.2 Million in 2021.

What is the growth rate of the APAC CRISPR Gene Editing Market?

The growth rate of the APAC CRISPR Gene Editing Market is 28.6%, with an estimated value of $4701.3 Million by 2031.

What is the forecasted size of the APAC CRISPR Gene Editing Market?

The APAC CRISPR Gene Editing Market is estimated to be worth $4701.3 Million by 2031.

Who are the key companies in the APAC CRISPR Gene Editing Market?

Key companies in the APAC CRISPR Gene Editing Market include Selected Key Players:, Abcam, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Caribou Biosciences, Inc., Cellecta, Inc., CRISPR Therapeutics AG, Editas Medicine, Inc. and GeneScript Biotech Corporation.

Table of Contents

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis
3 Segmentation of Asia Pacific Market by Offering
3.1 Market Overview by Offering
3.2 CRISPR Products
3.2.1 Kits & Enzymes
3.2.2 Databases & Libraries
3.2.3 Design Tools
3.2.4 Antibodies
3.2.5 CRISPR Plasmid & Vector
3.2.6 Other Products
3.3 CRISPR Services
3.3.1 gRNA Design & Vector Construction
3.3.2 Cell Line Engineering
3.3.3 Microbial Gene Editing
3.3.4 DNA Synthesis
3.3.5 Other Services
4 Segmentation of Asia Pacific Market by Application
4.1 Market Overview by Application
4.2 Biomedical Research & Therapy
4.2.1 Gene Therapy
4.2.2 Drug Discovery
4.2.3 Diagnostics
4.2.4 Other Biomedical Applications
4.3 Agriculture
4.4 Industrial Use
4.5 Other Applications
5 Segmentation of Asia Pacific Market by End User
5.1 Market Overview by End User
5.2 Pharmaceutical Companies
5.3 Biotechnology Companies
5.4 Academic Institutions & Research Centers
5.5 Other End Users
6 Asia-Pacific Market 2021-2031 by Country
6.1 Overview of Asia-Pacific Market
6.2 Japan
6.3 China
6.4 Australia
6.5 India
6.6 South Korea
6.7 Rest of APAC Region
7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
  • Abcam, Inc.
  • Agilent Technologies, Inc.
  • Applied StemCell, Inc.
  • Caribou Biosciences, Inc.
  • Cellecta, Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GeneCopoeia, Inc.
  • GeneScript Biotech Corporation
  • Horizon Discovery Group PLC
  • Integrated DNA Technologies, Inc.
  • Intellia Therapeutics Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Rockland Immunochemicals, Inc.
  • Synthego Corporation
  • System Biosciences LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • ToolGen, Inc.

List of Tables:

Table 1. Snapshot of Asia Pacific CRISPR Gene Editing Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Developing Roadmap of CRISPR Technology
Table 4. Private and Public Companies Investment in CRISPR Technology
Table 5. Comparison of CRISPR with Other Gene Editing Technologies
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Asia Pacific CRISPR Gene Editing Market
Table 8. Asia Pacific CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 9. Asia Pacific CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn
Table 10. Asia Pacific CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn
Table 11. Asia Pacific CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn
Table 12. Asia Pacific CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 13. Asia Pacific CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn
Table 14. Asia Pacific CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 15. APAC CRISPR Gene Editing Market by Country, 2021-2031, $ mn
Table 16. Japan CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 17. Japan CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 18. Japan CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 19. China CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 20. China CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 21. China CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 22. Australia CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 23. Australia CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 24. Australia CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 25. India CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 26. India CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 27. India CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 28. South Korea CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 29. South Korea CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 30. South Korea CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 31. CRISPR Gene Editing Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 32. Breakdown of World Market by Key Vendor, 2021, %
Table 33. Abcam, Inc.: Company Snapshot
Table 34. Abcam, Inc.: Business Segmentation
Table 35. Abcam, Inc.: Product Portfolio

List of Figures:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Asia Pacific CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 5. Categories of CRISPR-Cas Systems
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Asia Pacific CRISPR Gene Editing Market
Figure 8. Leading Causes of Death in the World, 2019-2020, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Asia Pacific CRISPR Gene Editing Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Five Forces Analysis of Asia Pacific CRISPR Gene Editing Market
Figure 14. Breakdown of Asia Pacific CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue
Figure 15. Asia Pacific Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)
Figure 16. Asia Pacific CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, $ mn
Figure 17. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, $ mn
Figure 18. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, $ mn
Figure 19. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, $ mn
Figure 20. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, $ mn
Figure 21. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, $ mn
Figure 22. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, $ mn
Figure 23. Asia Pacific CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, $ mn
Figure 24. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, $ mn
Figure 25. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, $ mn
Figure 26. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, $ mn
Figure 27. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, $ mn
Figure 28. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, $ mn
Figure 29. Breakdown of Asia Pacific CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue
Figure 30. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 31. Asia Pacific CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, $ mn
Figure 32. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, $ mn
Figure 33. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, $ mn
Figure 34. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, $ mn
Figure 35. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, $ mn
Figure 36. Asia Pacific CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, $ mn
Figure 37. Asia Pacific CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, $ mn
Figure 38. Asia Pacific CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, $ mn
Figure 39. Breakdown of Asia Pacific CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue
Figure 40. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 41. Asia Pacific CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, $ mn
Figure 42. Asia Pacific CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, $ mn
Figure 43. Asia Pacific CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, $ mn
Figure 44. Asia Pacific CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, $ mn
Figure 45. Breakdown of APAC CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue
Figure 46. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 47. CRISPR Gene Editing Market in Japan, 2021-2031, $ mn
Figure 48. CRISPR Gene Editing Market in China, 2021-2031, $ mn
Figure 49. CRISPR Gene Editing Market in Australia, 2021-2031, $ mn
Figure 50. CRISPR Gene Editing Market in India, 2021-2031, $ mn
Figure 51. CRISPR Gene Editing Market in South Korea, 2021-2031, $ mn
Figure 52. CRISPR Gene Editing Market in Rest of APAC, 2021-2031, $ mn
Figure 53. Growth Stage of Asia Pacific CRISPR Gene Editing Industry over the Forecast Period

Companies Mentioned

  • Selected Key Players:
  • Abcam, Inc.
  • Agilent Technologies, Inc.
  • Applied StemCell, Inc.
  • Caribou Biosciences, Inc.
  • Cellecta, Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GeneCopoeia, Inc.
  • GeneScript Biotech Corporation
  • Horizon Discovery Group PLC
  • Integrated DNA Technologies, Inc.
  • Intellia Therapeutics Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Rockland Immunochemicals, Inc.
  • Synthego Corporation
  • System Biosciences LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • ToolGen, Inc.

Methodology

Loading
LOADING...